News

Cogentis took home 1st place at inaugural new company/technology pitch at the GTC CNS Diseases Summit in Boston, MA 

Read more about the CNS Disesases Summit here.

Cogentis has been named 1 of 134 semifinalists in the prestigious 43North accelerator. 

Read 43North’s announcement here and a list of other semifinalists here.

Cogentis has been named 1 of 26 finalists (out of over 1500+ startups) in the prestigious MassChallenge accelerator. Support Cogentis at this year’s MC Awards Ceremony held in Boston on October 28.

Read MassChallenge’s announcement here.

We are proud to announce that Cydan Development, a sponsor of the prestigious MassChallenge accelerator, has awarded one of its five MassChallenge scholarships to Cogentis Therapeutics.

Read Cydan’s announcement here.

Cogentis has been named 1 of 26 finalists (out of over 1500+ startups) in the prestigious MassChallenge accelerator. Support Cogentis at this year’s MC Awards Ceremony held in Boston on October 28.

Read MassChallenge’s announcement here.

Cogentis was selected as 1 of 10 biotech teams (out of 300+ original teams) to move on to the finalist stage in the One Start Americas competition. The competition is sponsored by Oxbridge Biotech Roundtable and SR-One (VC arm of GSK).

Read OneStart announcement here.

View our OneStart semi-finalist video here.